TrialNeurology2024

Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ Study.

Thomas O Crawford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.